Summary

Parathyroid carcinoma is the least common malignancy among endocrine tumors. It varies in malignant potential from a minimally invasive local tumor with slow progression to an aggressive tumor with hematogenous metastasis and a rapid course, often with a fatal outcome because of unremitting hypercalcemia. The histopathologic pattern of these tumors more often shows prominent nuclear atypia, frequent mitosis, and an aberrant ploidy pattern with chromosomal rearrangements compared with benign parathyroid neoplasms. Recognition by the surgeon that the parathyroid tumor is malignant and performance of an adequate en bloc removal of the primary lesion, when appropriate, offer the best chance of local cure for a patient with this unusual malignancy.

REFERENCES

1. Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: A collective review. Ann Surg 1969:169:631.

2. Sandelin K, Auer G, Bondeson L, et al. Prognostic factors in parathyroid cancers: A review of 95 cases. World J Surg 1992:16:724.

3. Schantz A, Castleman B. Parathyroid carcinoma: A study of 70 cases. Cancer 1973:31:600.

4. Shane E, Bilezikian JP. Parathyroid carcinoma: A review of 62 patients. EndocrRev 1982:3:218.

5. Smith JF, Coombs RRH. Histological diagnosis of carcinoma of the parathyroid gland. J Clin Pathol 1984:37:1370.

6. Fujimoto Y, Obara T, Ito Y, et al. Localization and surgical resection of metastatic parathyroid carcinoma. World J Surg 1986; 10:5 39.

7. Dinnen JS, Greenwood RH, Jones JH, et al. Parathyroid carcinoma in familial hyperparathyroidism. J Clin Pathol 1977:30:966.

8. Frayha RA, Nassar VH, Dagher F, Salti IS. Familial parathyroid carcinoma. J Med Liban 1972;25:299.

9. Mallette LE. DNA quantitation in study of parathyroid lesions. Am J Clin Pathol 1992;98:305.

10. McHenry CR, Rosen IB, Walfish PG, Cooter N. Parathyroid crisis of unusual features in a child. Cancer 1993;71:1923.

11. Streeten E, Weinstein LS, Norton JA, et al. Studies in a kindred with parathyroid carcinoma. J Clin Endocrinol Metab 1992;75:362.

12. Wassif WS, Moniz CF, Friedman E, et al. Familial isolated hyperparathyroidism: A distinct genetic entity with increased risk of parathyroid cancer. J Clin Endocrinol Metab 1993;77:1485.

13. Christmas TJ, Chappie CR, Noble JG, et al. Hyperparathyroidism after neck irradiation. Br J Surg 1988:75:873.

14. Shapiro DM, Recant W, Hemmati M, et al. Synchronous occurrence of parathyroid carcinoma and adenoma in an elderly woman. Surgery 1989:106:929.

15. Granberg PO, Cedermark B, Farnebo LO, et al. Parathyroid tumors. Curr Probl Cancer 1985;9:1.

16. Sandelin K, Tullgren O, Famebo L. Clinical course of metastatic parathyroid cancer. World J Surg 1994;18:594.

17. Wang C, Gaz RD. Natural history of parathyroid carcinoma: Diagnosis, treatment, and results. Am J Surg 1985:149:522.

18. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: An update and review. World J Surg 1991 ;15:738.

19. Shortell CK, Andrus CH, Phillips CE, Schwartz SI. Carcinoma of the parathyroid gland: A 30 year experience. Surgery 1991;110:704.

20. Trigonis C, Cedermark B, Willems J, et al. Parathyroid carcinoma— Problems in diagnosis and treatment. Clin Oncol 1984; 10:11.

21. Segre GV. Receptors for parathyroid hormone and parathyroid hormone related protein. In: Bilezikian JP (ed), The Parathyroids. New York, Raven Press, 1994, p 213.

22. Murphy MN, Glennon PG, Diocee MS, et al. Nonsecretory parathyroid carcinoma of the mediastinum: Light microscopic, immunohistochem-ical, and ultrastructural features of a case and review of the literature. Cancer 1986;55:2468.

23. Doppman JL. Preoperative localization of parathyroid tissue in primary hyperparathyroidism. In: Bilezikian JP (ed), The Parathyroids. New York, Raven Press, 1994, p 553.

24. Kaplan EL, Yashiro T, Salti G. Primary hyperthyroidism in the 1990s. Ann Surg 1992:215:300.

25. Sandelin K, Thompson NW, Bondeson L. Dilemmas in management of parathyroid carcinoma. Surgery 1991:110:978.

26. Vetto JT, Brennan MF, Woodruf J, Burt M. Parathyroid carcinoma: Diagnosis and clinical history. Surgery 1993:114:882.

27. Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, et al. Parathyroid carcinoma: Features and difficulties in diagnosis and management. Surgery 1983;94:906.

28. McKeown PP, McGarity WC, Sewell CW. Carcinoma of the parathyroid gland: Is it overdiagnoses? Am J Surg 1984;147:292.

29. Bondeson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinomas. Am J Surg Pathol 1993; 17:820.

30. Parfitt AM. Parathyroid growth. In: Bilezikian JP (ed), The Parathyroids. New York, Raven Press, 1994, p 373.

31. Falkmer UG, Hagmar T, Auer G. Efficacy of combined image and flow cytometric DNA assessments in human breast cancer: A methodological study based on a routine histopathological material of 2024 excised tumor specimens. Anal Cell Pathol 1990;2:297.

32. Moberger B. DNA content and prognosis in endometrial carcinoma [Medical dissertation], Stockholm, Karolinska Institute, 1989.

33. Munck-Wikland E, Auer G, Kuylenstierna R, et al. Image cytometry DNA analysis of invasive squamous cell carcinoma of the esophagus. Anticancer Res 1989;93:545.

34. Tallroth Ekman E, Bergholm U, Backdahl M, et al. Nuclear DNA content and survival in medullary thyroid carcinoma. Cancer 1990:65:511.

35. August DA, Flynn SD, Jones MA, et al. Parathyroid carcinoma: The relationship of nuclear DNA content to clinical outcome. Surgery 1993; 113:290.

36. Bonjer HJ, Birkenhager JC, Bruining HA, et al. Single and multiglan-dular disease in primary hyperparathyroidism: Long term follow up studies, histological studies and DNA analyses in 693 patients. Presented at the 34th World Congress of Surgery of the ISS/SIC and the 12th World Congress of the CICD, Stockholm, 1991.

37. Bowlby LS, DeBault LE, Abraham SR. Flow cytometric DNA analysis of parathyroid glands: Relationships between nuclear DNA and pathologic classifications. Am J Pathol 1987:128:338.

38. Harlow S, Roth SI, Bauer K, Marshall RB. Flow cytometric DNA analysis of normal and pathologic parathyroid glands. Mod Pathol 1991; 4:310.

39. Howard S, Anderson C, Diels W, et al. Nuclear DNA density of parathyroid lesions. Pathol Res Pract 1992:188:497.

40. Joensuu H, Klemi PJ. DNA aneuploidy in adenomas of endocrine organs. Am J Pathol 1988:132:145.

41. Obara T, Fujimoto Y, Kanaji Y, et al. Flow cytometric DNA analysis of parathyroid tumors. Cancer 1990:66:1556.

42. Obara T, Okamoto T, Yamashita T, et al. Surgical and medical management of patients with pulmonary metastases from parathyroid carcinoma. Surgery 1993:114:1040.

43. Shenton BK, Ellis H, Johnston IDA, Farndon JR. DNA analysis and parathyroid pathology. World J Surg 1990;14:296.

44. Hakim JP, Levine MA. Absence of p53 mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 1994;78:103.

45. Arnold A. Molecular basis of primary hyperparathyroidism. In: Bilezikian JP (ed), The Parathyroids. New York, Raven Press, 1994, p 407.

46. Arnold A, Kim HG, Gaz RD, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83:2034.

47. Cryns VL, Thor A, Xy HJ, et al. Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N Engl J Med 1994;330:757

48. Kytola S, Farnebo F, Obara T, et al. Patterns of chromosomal imbalances in parathyroid carcinomas. Am J Pathol 2000:157:579.

49. Chen JD, Morrison C, Zhang C, et al. Hyperparathyroidism-jaw tumour syndrome. J Intern Med 2003:253:634.

50. Shattuck TM, Valimaki S, Obara T, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003:349:1722.

51. Howell VM, Haven CJ, Kahnoski K, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 2003:40:657.

52. Kebebew E, Clark OH. Parathyroid adenoma, hyperplasia, and carcinoma: Localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surg Oncol Clin N Am 1998;7:721.

53. Rodan GA. Bisphosphonates and primary hyperparathyroidism. J Bone Miner Res 2002; 17(Suppl 2):N150.

54. Ralston SH, Patel U, Fraser WD, et al. Comparison of three intravenous bisphosphonates in cancer associated hypercalcemia. Lancet 1989:2:1180.

55. Glover DJ, Shaw L, Glick JH, et al. Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid. Ann Intern Med 1985;103:55.

56. Wynne AG, Heerden van J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: Clinical and pathologic features in 43 patients. Medicine (Baltimore) 1992;71:197.

57. Fitko R, Roth SI, Hines JR, et al. Parathyromatosis in hyperparathyroidism. Hum Pathol 1990;21:234.

58. Fraker DL, Travis WD, Merendono JJ Jr, et al. Locally recurrent parathyroid neoplasms as a cause for recurrent and persistent primary hyperparathyroidism. Ann Surg 1991;213:58.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment